These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7038420)

  • 41. Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study.
    Mulder JH; Dodion P; Cavalli F; Czarnetzki B; Clavel M; Thomas D; Suciu S; Rozencweig M
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1297-301. PubMed ID: 6891928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
    Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vindesine effect in myeloid leukemia.
    Baccarani M; Zaccaria A; Corbelli G; Tura S
    Cancer Chemother Pharmacol; 1982; 8(3):255-9. PubMed ID: 6957273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of vindesine bolus and infusion.
    Jackson DV; Sethi VS; Long TR; Muss HB; Spurr CL
    Cancer Chemother Pharmacol; 1984; 13(2):114-9. PubMed ID: 6467494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC).
    Brenner J; Magill GB; Wissel P; Sordillo PP
    Cancer; 1983 Oct; 52(7):1142-5. PubMed ID: 6349786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative Group.
    Fosså SD; Denis L; van Oosterom AT; de Pauw M; Stoter G
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):473-5. PubMed ID: 6305668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.
    Pazdur R; Rossof AH; Chandra G; Bonomi PD; Slayton RE; Wolter J
    Cancer Chemother Pharmacol; 1982; 9(1):41-4. PubMed ID: 7139851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
    Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
    J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
    Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Phase II study of the treatment of CML blast crisis with vindesine and prednisone].
    Jehn U; Mezger J
    Onkologie; 1984 Dec; 7(6):342-5. PubMed ID: 6396561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
    Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
    Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
    Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
    Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
    [No Abstract]   [Full Text] [Related]  

  • 59. [Vindesine, a new cytostatic agent from the vinca alkaloids].
    Goldhirsch A; Joss R; Sonntag RW; Brunner KW
    Dtsch Med Wochenschr; 1980 Jun; 105(26):931-5. PubMed ID: 6931709
    [No Abstract]   [Full Text] [Related]  

  • 60. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.